IDH2 and astrocytoma (excluding glioblastoma): Additionally, mutations in numerous genes with known functions related to maintaining chromosomal stability in many tumor types (Table 1) [114] have been identified in approximately 10% IDH-mutant astrocytomas, and mutations in these genes are significantly more frequent in cases with elevated CNV and poor clinical outcomes [71, 96, 97].